CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

LABTLakewood-Amedex Biotherapeutics Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $0.96 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$2.26M
CountryUSA
INSTITUTIONAL OWNERSHIP
Institutional holders6
Shares held97,820
Value$166.68K
Percent of shares outstanding4.13%
As of quarter end2026-06-30
RECENT NEWS
  • Lakewood-Amedex reports 97% E. coli growth inhibition with Bisphosphocin Nu-8
  • Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
  • Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
  • Lakewood-Amedex reports positive data for Nu-3 against diabetic foot ulcer isolates
  • Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Lakewood-Amedex Biotherapeutics Inc. (LABT) · Stock Price, Institutional Holdings, News · CatalystPit